Piramal Pharma
BSE 543635
8 stories, newest first.
- Piramal Pharma to host Q2 and H1 FY2027 earnings conference call on 28 October 2026
- Board meeting on 27 October 2026 to consider and approve Q2 and H1 unaudited results
- Rapid fire caller query on Piramal Pharma asking about long-term hold
- Bayer sales & distribution arrangement to expire on 31st December, 2026; will not be renewed
- Clarification: Ontario's $1.7 Million LSSUF Funding for Aurora Facility Not Material
- Viral Gandhi appointed Chief Technology Officer from 1 October 2026
- Leadership change at Piramal Critical Care: Jeffrey Hampton to retire, Brian Guy appointed President & COO
- GST Order Confirms Rs. 4.06 Crore ITC Demand With Equal Penalty; Appeal Planned
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.